Skip to main content
MedWatcherBeta

Loading research and source information…

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH for Fatty liver disease and MASH: evidence and status · MedWatcher